CPRX - Catalyst Pharmaceuticals: New Products In Proving Phase
2024-07-06 03:24:42 ET
Summary
- Catalyst's product portfolio has grown through acquisitions to three.
- Two of these, FYCOMPA and AGAMREE, are relatively new, with AGAMREE having reported but a single partial quarter revenue.
- Catalyst remains on the outlook for additional business development opportunities.
...
Catalyst Pharmaceuticals: New Products In Proving Phase